Axsome projects Auvelity peak sales of at least $8B following Alzheimer's agitation approval and June launch
Axsome Therapeutics, Inc · PHARMACEUTICAL PREPARATIONS · Now $230.25
+5.2% in 7d after detection
Post-detection moves
1h
—
1d
-0.3%
3d
-1.6%
7d
+5.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS